MOH's Medicaid focus, dual-eligible expansion and stronger share gains make it stand out against UNH in managed care.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MOH's premium valuation reflects confidence in growth, acquisitions and cash strength, even as elevated medical costs pressure margins.
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina (MOH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Centene (CNC) and Molina Healthcare (MOH) have "compelling" EPS upside potential and could see their
Molina Healthcare and The MolinaCares Accord have awarded a major grant to the Northeast Independent Living Program to fund a 12 month pilot for young adults with disabilities in Massachusetts. The initiative, run by NILP, is designed to address support gaps for underserved young adults as they transition to greater independence. The program underscores Molina Healthcare’s focus on community impact and aligns with its broader mission of serving complex and vulnerable populations. Molina...
Pfizer (NYSE:PFE) at $25.75, Molina Healthcare (NYSE:MOH) at $186.80, and Halliburton (NYSE:HAL) at $41.29 trade at defensive, cash-generative valuations. Michael Burry purchased these shares for their real earnings and margin stability, and with inflation still pressuring margins across the market, names that generate cash, hold pricing power, and trade at sober multiples carry a structural ... Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year.
The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
SEM's Q1 EPS misses due to higher expenses and weaker patient days, even as revenues top estimates and rehab segment growth partly offsets pressure.
Vanguard Capital Management has disclosed a passive stake above 5% in Molina Healthcare, NYSE:MOH. The filing signals that a large institutional investor now holds a significant ownership position in the company. The stake is reported as passive, with no indication of activist intentions at this time. Molina Healthcare, NYSE:MOH, last closed at $192.7, with the stock up 9.5% over the past week and 38.3% over the past month. Returns over longer periods have been weaker, including a 39.4%...
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.
BofA Securities upgrades Elevance Health and gives a rare double upgrade to Centene and Molina Healthcare.
HUM posts Q1 earnings beat as premiums surge and membership grows, but rising costs and benefit ratio pressure weigh on profit.
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
CNC tops Q1 estimates on strong premiums, lifts 2026 outlook with higher revenue and EPS guidance despite membership decline and rising costs.
Universal Health tops Q1 estimates as behavioral health admissions and patient days rise, driving revenue growth despite higher operating costs.
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Is MOH a good stock to buy? We came across a bullish thesis on Molina Healthcare, Inc. on Dasam’s Substack. In this article, we will summarize the bulls’ thesis on MOH. Molina Healthcare, Inc.’s share was trading at $150.12 as of April 20th. MOH’s trailing and forward P/E were 16.83 and 29.76 respectively according to Yahoo Finance. Molina Healthcare, […]
Molina Healthcare, Inc. recently reported first‑quarter 2026 results showing revenue of US$10.80 billion, GAAP net income of US$14 million, and GAAP earnings of US$0.27 per diluted share, alongside much higher adjusted earnings and modest declines in revenue and membership. The company also reaffirmed its full‑year 2026 outlook for about US$42.00 billion in premium revenue and at least US$5.00 in adjusted earnings per diluted share, while booking a US$93 million impairment tied to its...
Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) jumped 13.2% in the afternoon session after the company reported stronger-than-expected first-quarter earnings.